Prevalence and related factors of the absence of anemia among Chinese chronic hemodialysis patients: A multicenter cross-sectional study

International Urology and Nephrology

Volumn 46, Issue 8, 2014, Pages 1651-1654

  Wan, Qijun ^a   He, Yongcheng ^a   Zhang, Wanfan ^b   Wu, Qiang ^c   Xiong, Zibo ^d  

^a THE FIRST AFFILIATED HOSPITAL OF SHENZHEN UNIVERSITY   (China)

^b SHENZHEN PEOPLE'S HOSPITAL   (China)

^c the Fourth Hospital   (China)

^d PEKING UNIVERSITY SHENZHEN HOSPITAL   (China)

Author keywords

Adult polycystic kidney disease; Anemia; Endogenous erythropoietin; Erythropoiesis stimulating agents (ESA).; Hemodialysis; r HuEPO independence

Indexed keywords

ERYTHROPOIETIN; HEMOGLOBIN; RECOMBINANT ERYTHROPOIETIN; ANTIANEMIC AGENT; IRON; RECOMBINANT PROTEIN;

ADULT; ANDROGEN THERAPY; ANEMIA; ARTICLE; BLOOD TRANSFUSION; CHINESE; CLINICAL FEATURE; CROSS-SECTIONAL STUDY; ECHOGRAPHY; FEMALE; HEALTH SURVEY; HEMODIALYSIS; HEPATITIS C; HUMAN; IRON METABOLISM; KIDNEY CYST; KIDNEY POLYCYSTIC DISEASE; LIVER CYST; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PREDICTOR VARIABLE; PREVALENCE; TREATMENT DURATION; ADVERSE EFFECTS; AGE; AGED; BLOOD; CHINA; CLINICAL TRIAL; CYSTS; LIVER DISEASES; METABOLISM; MIDDLE AGED; POLYCYSTIC KIDNEY DISEASES; RENAL INSUFFICIENCY, CHRONIC; RENAL REPLACEMENT THERAPY; TIME;

ADULT; AGE FACTORS; AGED; ANEMIA; CHINA; CROSS-SECTIONAL STUDIES; CYSTS; ERYTHROPOIETIN; FEMALE; HEMATINICS; HEMOGLOBINS; HEPATITIS C; HUMANS; IRON; LIVER DISEASES; MALE; MIDDLE AGED; POLYCYSTIC KIDNEY DISEASES; PREVALENCE; RECOMBINANT PROTEINS; RENAL DIALYSIS; RENAL INSUFFICIENCY, CHRONIC; TIME FACTORS;

EID: 84906726392     PISSN: 03011623     EISSN: 15732584     Source Type: Journal    
DOI: 10.1007/s11255-013-0581-1     Document Type: Article

References (19)

1. Kuo CC, Lee CT, Chung CH, Su Y, Chen JB (2005) Recombinant human erythropoietin independence in chronic hemodialysis patients: clinical features, iron homeostasis and erythropoiesis. Clin Nephrol 63:92-97 (Pubitemid 40298043)
2. Goodkin DA, Fuller DS, Robinson BM et al (2011) Naturally occurring higher hemoglobin concentration does not increase mortality among hemodialysis patients. J Am Soc Nephrol 22:358-365
3. Verdalles U, Abad S, Vega A, Caro CR, Ampuero J, Jofre R, Lopez-Gomez JM (2011) Factors related to the absence of anemia in hemodialysis patients. Blood Purif 32:69-74
4. Pisoni RL, Gillespie BW, Dickinson DM, Chen K, Kutner MH, Wolfe RA (2004) The dialysis outcomes and Practice patterns Study (DOPPS): design, data elements, and methodology. Am J Kidney Dis 44:7-15
5. Pisoni RL, Bragg-Gresham JL, Young EW et al (2004) Anemia management and outcomes from 12 countries in the dialysis and practice patterns study (DOPPS). Am J Kidney Dis 44:94-111 (Pubitemid 38880932)
6. Takeda A, Toda T, Shinohara S, Mogi Y, Matsui N (2002) Contributing to higher hematocrit levels in hemodialysis patients not receiving recombinant human erythropoietin. Am J Kidney Dis 40:104-109 (Pubitemid 34701217)
7. Saab G, Young DO, Gincherman Y, Giles K, Norwood K, Coyne DW (2007) Prevalence of vitamin D deficiency and the safety and effectiveness of monthly ergocalciferol in hemodialysis patients. Nephron Clin Pract 105:c132-c138 (Pubitemid 46215207)
8. Charles G, Lundin AP 3rd, Delano BG, Brown C, Friedman EA (1981) Absence of anemia in maintenance hemodialysis. Int J Artif Organs 4:277-279 (Pubitemid 12136300)
9. Di Iorio B, Iodice C (2002) High hemoglobin in dialysis patients not receiving rHuEPO. Am J Kidney Dis 40:1349 (Pubitemid 35403152)
10. Barton IK, Mansell MA (1987) Erythrocytosis induced by danazol in an anephric patient. Br Med J (Clin Res Ed) 7:294-300
11. Lopez-Gomez JM, Portolés JM, Aljama P (2008) Factors that condition the response to erythropoietin in patients on hemodialysis and their relation to mortality. Kidney Int Suppl 111:S75-S81
12. Meyrier A, Simon P, Boffa G, Brissot P (1981) The liver and erythropoiesis in chronic renal failure. Nephron 29:3-6 (Pubitemid 12241804)
13. Navarro JF, Mora C, Macía M, García J (2002) Randomized prospective comparison between erythropoietin and androgens in CAPD patients. Kidney Int 61:1537-1544 (Pubitemid 34304516)
14. Cohen NN (1960) Polycythemia associated with bilateral unilocular renal cysts. Arch Intern Med 105:301-304
15. Feustel A, Bellmann H, Hefftler U (1970) Renal polycythemia as a facultative leading symptom in kidney tumors, hydronephrosis ad cystic kidney. Urol Nephrol 63:705-714
16. Eckardt KU, Drüeke T, Leski M, Kurtz A (1991) Unutilized reserves: the production capacity for erythropoietin appears to be conserved in chronic renal disease. Contrib Nephrol Basel Karger 88:18-31
17. Khurana A, Níkel A, Narayanan M, Foulks C (2008) Effect of hepatitis C infection on anemia in hemodialysis patients. Hemodial Int 12:94-99 (Pubitemid 351247385)
18. Simon P, Meyrier A, Tanquerel T, Ang KS (1980) Improvement of anaemia in haemodialysed patients after viral or toxic hepatic cytolysis. Br Med J 29:892-894 (Pubitemid 10105563)
19. Floege J, Eitner F (2007) Acquired cystic kidney disease and malignancies in chronic kidney disease. In: Feehally J, Floege J, Johnson RJ (eds) Comprehensive Clinical Nephrology. Mosby Elsevier, Philadelphia, pp 911-916